Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Mammalia
Entry Details
ID
411
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P05155 (Created: 1987-08-13 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
IC1_HUMAN
Protein Name
Plasma protease C1 inhibitor
Gene
SERPING1
Organism Scientific
Homo sapiens
Organism Common
Human
Lineage
Eukaryota
Metazoa
Chordata
Craniata
Vertebrata
Euteleostomi
Mammalia
Eutheria
Euarchontoglires
Primates
Haplorrhini
Catarrhini
Hominidae
Homo
Protein Length [aa]
500
Protein Mass [Da]
55154
Features
Type
Description
Status
Start
End
signal peptide
1
22
chain
Plasma protease C1 inhibitor
23
500
disulfide bond
123
428
disulfide bond
130
205
region of interest
7 X 4 AA tandem repeats of [QE]-P-T-[TQ]
85
119
glycosylation site
N-linked (GlcNAc...)
25
25
glycosylation site
O-linked (GalNAc...)
48
48
glycosylation site
O-linked (GalNAc...)
64
64
glycosylation site
N-linked (GlcNAc...)
69
69
glycosylation site
O-linked (GalNAc...)
71
71
glycosylation site
N-linked (GlcNAc...)
81
81
glycosylation site
O-linked (GalNAc...)
83
83
glycosylation site
O-linked (GalNAc...)
88
88
glycosylation site
O-linked (GalNAc...)
92
92
glycosylation site
O-linked (GalNAc...)
96
96
glycosylation site
N-linked (GlcNAc...)
238
238
glycosylation site
N-linked (GlcNAc...)
253
253
glycosylation site
N-linked (GlcNAc...); in variant TA
272
272
glycosylation site
N-linked (GlcNAc...)
352
352
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2; MO)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2; AT)
0
0
sequence variant
(in HAE; type 2; DA; dbSNP:rs28940870)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in dbSNP:rs4926)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in HAE; type 2; MA)
0
0
sequence variant
(in HAE; type 2; WE)
0
0
sequence variant
(in HAE; type 2)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in dbSNP:rs1803212)
0
0
sequence variant
(in dbSNP:rs11229062)
0
0
sequence variant
(in HAE; type 1)
0
0
sequence variant
(in dbSNP:rs11546660)
0
0
sequence variant
(in HAE; type 2)
84
138
sequence variant
(in HAE; type 2; TA; creates a new glycosylation site)
273
273
strand
167
169
strand
216
226
strand
287
301
strand
309
313
strand
320
337
strand
342
350
strand
353
362
strand
391
399
strand
402
408
strand
417
419
strand
441
449
strand
451
463
strand
468
470
strand
477
483
strand
488
495
helix
135
157
helix
171
183
helix
187
197
helix
206
211
helix
234
244
helix
255
268
helix
367
373
helix
376
387
helix
409
413
helix
414
416
helix
421
424
repeat
1
85
88
repeat
2
89
92
repeat
3
93
96
repeat
4
97
100
repeat
5
101
104
repeat
6
105
108
repeat
7
116
119
site
Reactive bond for chymotrypsin
465
466
site
Reactive bond
466
467
turn
269
272
turn
338
341
turn
428
430
turn
484
487
SP Length
22
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MASRLTLLTLLLLLLAGDRASS
Sequence
MASRLTLLTLLLLLLAGDRASS
NP
N
ATSSSSQDPESLQDRGEGKVAT
T
VI
SKMLFVEPILEVS
S
LPTT
N
S
T
TNSATKITA
N
T
T
D
EPTT
QPTT
EPTT
QPTI
QPTQ
PTTQ
LPTDSPT
QPTT
GSFCPGPVTLCSDLE
SHSTEAVLGDALVDFS
LKLYHAF
SAMKKVETN
MAF
S
PFSIASLLTQVLL
GAG
ENTKTNLESIL
SYP
KDFTC
VHQALK
GFTT
KGVTSVSQIFH
SPDLAIR
DTFVNASRTLY
SSSPRV
LS
N
N
SDANLELINTWVAK
NTNN
K
ISRLLDSLPSDTR
LVLLNAIYLSAKWK
T
TFDPKKT
RMEPF
HFKNSV
IKVPMMNSKKYPVAHFID
QTLK
AKVGQLQLS
H
N
LSLVILVPQN
LKHR
LEDMEQA
LS
PSVFKAIMEKLE
MSK
FQPTLLTLP
R
I
KVTTSQD
MLSIM
EKL
EFF
D
FSYD
LNL
CGL
TEDPDLQVSA
MQHQTVLEL
T
ETGVEAAAASAIS
V
A
RT
LLV
FEVQQP
FLFVLWD
QQHK
FPVFMGRV
YDPRA
Original
MASRLTLLTLLLLLLAGDRASSNPNATSSSSQDPESLQDRGEGKVATTVI
SKMLFVEPILEVSSLPTTNSTTNSATKITANTTDEPTTQPTTEPTTQPTI
QPTQPTTQLPTDSPTQPTTGSFCPGPVTLCSDLESHSTEAVLGDALVDFS
LKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYP
KDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRV
LSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWK
TTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLS
HNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPR
IKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELT
ETGVEAAAASAISVARTLLVFEVQQPFLFVLWDQQHKFPVFMGRVYDPRA
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11